Dare Bioscience, Inc.
DARE· Nasdaq
Filed Nov 13, 2018 · 10-Q · 44 days after period end · 0001564590-18-029135
| Metric | Q3 2018 | Q3 2017 | Q3 2016 | Q3 2015 |
|---|---|---|---|---|
| Net Income | -$2.57M | -$1.63M | -$16.11K | -$10.55M |
| EPS Diluted | -$0.23 | -$0.33 | -$0.02 | -$0.39 |
The same fiscal quarter, prior years. Thaler holds no estimates to compare against.
Dare Bioscience, Inc. · CIK 1401914 · Engraved from SEC EDGAR
ended Sep 30, 2018 · filed Nov 13, 2018 · 44 d after period end